BLEGD (Branded Legacy) LT-Debt-to-Total-Asset: 3.51 (As of Dec. 2021)


What is Branded Legacy LT-Debt-to-Total-Asset?

Branded Legacy BLEGD LT-Debt-to-Total-Asset is 3.51 as of Dec. 2021.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Branded Legacy's long-term debt to total assests ratio for the quarter that ended in Dec. 2021 was 3.51.

Branded Legacy's long-term debt to total assets ratio increased from Dec. 2020 (1.01) to Dec. 2021 (3.51). It may suggest that Branded Legacy is progressively becoming more dependent on debt to grow their business.

Branded Legacy  (OTCPK:BLEGD) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Branded Legacy LT-Debt-to-Total-Asset Related Terms

Branded Legacy LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Branded Legacy's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Branded Legacy LT-Debt-to-Total-Asset Chart

Branded Legacy Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.00 0.00 1.02 1.01 3.51

Branded Legacy Quarterly Data
Dec15 Dec16 Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 1.32 1.92 2.22 3.51

Branded Legacy LT-Debt-to-Total-Asset Calculation

Branded Legacy's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (A: Dec. 2021 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2021 )/Total Assets (A: Dec. 2021 )
=0.421/0.12
=3.51

Branded Legacy's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (Q: Dec. 2021 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2021 )/Total Assets (Q: Dec. 2021 )
=0.421/0.12
=3.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 3.51 mean?
Branded Legacy (BLEGD) has a LT-Debt-to-Total-Asset of 3.51 as of Dec. 2021. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Branded Legacy and its competitors.
Is Branded Legacy's LT-Debt-to-Total-Asset too high?
Branded Legacy's current LT-Debt-to-Total-Asset is 3.51.
How does Branded Legacy's LT-Debt-to-Total-Asset compare to UPDC and RIBT?
Branded Legacy's LT-Debt-to-Total-Asset of 3.51 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Branded Legacy and its competitors. Branded Legacy's current LT-Debt-to-Total-Asset is 3.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Branded Legacy stock overvalued right now?
Branded Legacy (BLEGD) has a current LT-Debt-to-Total-Asset of 3.51. The current LT-Debt-to-Total-Asset is 3.51. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Branded Legacy (BLEGD), the current LT-Debt-to-Total-Asset is 3.51 as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Branded Legacy Business Description

Address 751 North Drive, Suite 9, Melbourne, FL, USA, 32934
Branded Legacy Inc provides high-level strategic advisory and operational transformation services focused on complex research, clinical development, and data-intensive organizations. Branded Legacy specializes in supporting large-scale international research consortia, platform clinical trials, and institutional/government data science initiatives. The core operations center on diagnosing operational inefficiencies, redesigning legacy systems, and implementing transparent, high-impact solutions that deliver measurable results.